Profissionais de saúde Página 2

ECDC - Data collection on COVID-19 outbreaks in closed settings with a completed vaccination programme: long-term care facilities

European Centre for Disease Prevention and ControlThe main aim of this activity is to collect information on the severity of breakthrough COVID-19 infections in outbreaks, by SARS-CoV-2 variant and vaccine product. This activity is not intended...

ECDC - Overview of the implementation of COVID-19 vaccination strategies and deployment plans in the EU/EEA

European Centre for Disease Prevention and Control

This report provides an updated overview of the progress of national COVID-19 vaccination strategies in EU/EEA countries.

ECDC - Objectives of vaccination strategies against COVID-19

European Centre for Disease Prevention and Control

This document provides an overview of the possible goals of vaccination against COVID-19 and reflects on potential implications.

ECDC - Interim guidance on the benefits of full vaccination against COVID-19 for transmission and implications for non-pharmaceutical interventions

European Centre for Disease Prevention and ControlCOVID-19 vaccines licensed in the EU/EEA have been shown during clinical trials to be highly effective in providing protection against symptomatic and severe COVID-19. Evidence from real-life...

ECDC - Reinfection with SARS-CoV-2: implementation of a surveillance case definition within the EU/EEA

European Centre for Disease Prevention and ControlReinfection with SARS-CoV-2 has been reported both within the European Union/European Economic Area (EU/EEA) and globally. This report summarises the available evidence about reinfection and...

AMP - Obesity and COVID-19: Present and Future

Acta Médica PortuguesaCom a chegada da COVID-19 à Europa e depois aos Estados Unidos, começou a avolumar-se a evidência que apontava a obesidade como uma das principais comorbilidades associadas a doença grave por COVID-19. Um dos primeiros...

NEJM - Thrombotic Thrombocytopenia after ChAdOx1 nCov-19 Vaccination

The New England Journal of MedicineSeveral cases of unusual thrombotic events and thrombocytopenia have developed after vaccination with the recombinant adenoviral vector encoding the spike protein antigen of severe acute respiratory syndrome...

AMP - Genomic Insights into the Human Susceptibility to SARS-CoV-2 Infection

Acta Médica PortuguesaOne year after the first reported case of COVID-19 in Portugal, on the 2nd of March 2020, we are acquiring knowledge at an unprecedented pace on this new infectious disease caused by the newly emerged SARS-CoV-2 virus. We...

NEJM - Thrombosis and Thrombocytopenia after ChAdOx1 nCoV-19 Vaccination

The New England Journal of MedicineWe report findings in five patients who presented with venous thrombosis and thrombocytopenia 7 to 10 days after receiving the first dose of the ChAdOx1 nCoV-19 adenoviral vector vaccine against coronavirus...

NEJM - On the Shoulders of Giants — From Jenner’s Cowpox to mRNA Covid Vaccines

The New England Journal of MedicineIn December 2020, on the basis of safety and efficacy data generated in two large, placebo-controlled studies, the Food and Drug Administration (FDA) issued emergency use authorizations for two mRNA vaccines for...

ECDC - Rollout of COVID-19 vaccines in the EU/EEA: challenges and good practice

European Centre for Disease Prevention and Control

This document outlines the key challenges that countries are facing with the COVID-19 vaccination rollout and lessons learned to mitigate these challenges.

ECDC - Risk of SARS-CoV-2 transmission from newly-infected individuals with documented previous infection or vaccination

European Centre for Disease Prevention and ControlMore than one year into the SARS-CoV-2 pandemic, over 120 million people have been infected with the virus across more than 200 countries. Reinfections following natural infections with the same...

AMP - The Impact of the COVID-19 Pandemic on Children’s Health in Portugal: The Parental Perspective

Acta Médica PortuguesaThe COVID-19 pandemic poses unprecedented challenges for healthcare services and has led to changes in the usage pattern of the pediatric population. We aimed to describe the impact of COVID-19 on children’s health,...

JAMA - Effect of Intermediate-Dose vs Standard-Dose Prophylactic Anticoagulation on Thrombotic Events, Extracorporeal Membrane Oxygenation Treatment, or Mortality Among Patients With COVID-19 Admitted

JAMA NETWORK

The results do not support routine empirical use of intermediate-dose prophylactic anticoagulation in unselected patients with COVID-19 admitted to the ICU.

AMP - Abordagem da Cefaleia no Doente com COVID-19

Acta Médica PortuguesaHeadache is one of the most common neurological symptoms of COVID-19. It has an estimated prevalence of 6% to 71% with most studies reporting 6% to 21%. It often appears simultaneously with other COVID-19 symptoms, is...

ECDC - Data collection on COVID-19 outbreaks in closed settings with a completed vaccination programme: long-term care facilities

ECDC - Overview of the implementation of COVID-19 vaccination strategies and deployment plans in the EU/EEA

ECDC - Objectives of vaccination strategies against COVID-19

ECDC - Interim guidance on the benefits of full vaccination against COVID-19 for transmission and implications for non-pharmaceutical interventions

ECDC - Reinfection with SARS-CoV-2: implementation of a surveillance case definition within the EU/EEA

AMP - Obesity and COVID-19: Present and Future

NEJM - Thrombotic Thrombocytopenia after ChAdOx1 nCov-19 Vaccination

AMP - Genomic Insights into the Human Susceptibility to SARS-CoV-2 Infection

NEJM - Thrombosis and Thrombocytopenia after ChAdOx1 nCoV-19 Vaccination

NEJM - On the Shoulders of Giants — From Jenner’s Cowpox to mRNA Covid Vaccines

ECDC - Rollout of COVID-19 vaccines in the EU/EEA: challenges and good practice

ECDC - Risk of SARS-CoV-2 transmission from newly-infected individuals with documented previous infection or vaccination

AMP - The Impact of the COVID-19 Pandemic on Children’s Health in Portugal: The Parental Perspective

JAMA - Effect of Intermediate-Dose vs Standard-Dose Prophylactic Anticoagulation on Thrombotic Events, Extracorporeal Membrane Oxygenation Treatment, or Mortality Among Patients With COVID-19 Admitted

AMP - Abordagem da Cefaleia no Doente com COVID-19

Categorias

Arquivo